BioCrude Technologies USA, Inc. financial data

Industry
Refuse Systems
Location
1255 Phillips Square, Suite 605, Montreal, Quebec, Canada
State of incorporation
Nevada
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.77 %
Debt-to-equity -111 % +1.54%
Return On Equity 137 % +30.8%
Return On Assets -1.51K % -55.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.8M shares +0.11%
Common Stock, Shares, Outstanding 50.9M shares +0.16%
Entity Public Float 0 USD
Common Stock, Value, Issued 50.9K USD +0.16%
Weighted Average Number of Shares Outstanding, Basic 50.8M shares +0.1%
Weighted Average Number of Shares Outstanding, Diluted 50.8M shares +0.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
General and Administrative Expense 302K USD +62.1%
Operating Income (Loss) -302K USD -62.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -305K USD -60.8%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 17.1K USD +4035%
Property, Plant and Equipment, Net 14.8K USD -12%
Assets 31.9K USD +84.6%
Liabilities, Current 291K USD +40.4%
Liabilities 291K USD +40.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 28.7K USD -0.08%
Retained Earnings (Accumulated Deficit) -9.32M USD -3.38%
Stockholders' Equity Attributable to Parent -255K USD -36.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -259K USD -36.4%
Liabilities and Equity 31.9K USD +84.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -79.4K USD -428%
Net Cash Provided by (Used in) Financing Activities 79.5K USD +430%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 50.9M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.34K USD +98.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 126 USD -69.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 418K USD +13.9%
Depreciation 1.09K USD +6.9%
Payments to Acquire Property, Plant, and Equipment 0 USD
Property, Plant and Equipment, Gross 34.8K USD +6.88%
Additional Paid in Capital 9.08M USD +3.81%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 3.76K USD -1.37%